{
    "root": "e8b6cea1-8a7f-4255-8a24-ff96d6ceece2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Bisoprolol fumarate",
    "value": "20230626",
    "ingredients": [
        {
            "name": "BISOPROLOL FUMARATE",
            "code": "UR59KN573L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3128"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "bisoprolol fumarate tablets indicated management hypertension . may used alone combination antihypertensive agents .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "dose bisoprolol fumarate tablets must individualized needs patient . usual starting dose 5 mg daily . patients , 2.5 mg may appropriate starting dose ( bronchospastic disease ) . antihypertensive effect 5 mg inadequate , dose may increased 10 mg , necessary , 20 mg daily . patients renal hepatic impairment patients hepatic impairment ( hepatitis cirrhosis ) renal dysfunction ( creatinine clearance less 40 ml/min ) , initial daily dose 2.5 mg caution used dose-titration . since limited data suggest bisoprolol fumarate dialyzable , replacement necessary patients undergoing dialysis . geriatric patients necessary adjust dose elderly , unless also significant renal hepatic dysfunction ( geriatric ) . pediatric patients pediatric experience bisoprolol fumarate tablets .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "hepatitis (DOID:2237)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2237"
            },
            {
                "text": "cirrhosis (DOID:5082)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5082"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "bisoprolol fumarate tablets , usp , supplied 5 mg 10 mg tablets . 5 mg tablet pink color coated tablet , capsule shaped , convex scored tablets debossed \u201c 6|6 \u201d one side \u201c \u201d side , supplied follows : bottles 30 ( unit-of-use ) ndc 43547-616-03 bottles 100 ndc 43547-616-10 bottles 500 ndc 43547-616-50 10 mg tablet white color coated tablet , round shaped , convex tablets debossed \u201c 6 7 \u201d one side \u201c \u201d side , supplied follows : bottles 30 ( unit-of-use ) ndc 43547-617-03 bottles 100 ndc 43547-617-10 bottles 500 ndc 43547-617-50 store 20 oc 25oc ( 68 ofto 77of ) ; excursions permitted 15 oc 30oc ( 59 ofto 86of ) [ usp controlled room temperature ] . protect moisture . dispense tight , light resistant containers . distributed : solco healthcare us , llc somerset , nj 08873 , usa manufactured : prinston laboratories charlotte , nc 28206 , usa revised : 06/2023 9040560-01",
    "adverseReactions": "bisoprolol fumarate tablets contraindicated patients cardiogenic shock , overt cardiac failure , second third degree av block , marked sinus bradycardia .",
    "indications_original": "Bisoprolol fumarate tablets are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.",
    "contraindications_original": "The dose of bisoprolol fumarate tablets must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose (see\n                        Bronchospastic Disease in WARNINGS\n                     ). If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily.\n                  \n                     Patients with Renal or Hepatic Impairment\n                  \n                  In patients with hepatic impairment (hepatitis or cirrhosis) or renal dysfunction (creatinine clearance less than 40 mL/min), the initial daily dose should be 2.5 mg and caution should be used in dose-titration. Since limited data suggest that bisoprolol fumarate is not dialyzable, drug replacement is not necessary in patients undergoing dialysis.\n                  \n                     Geriatric Patients\n                  \n                  It is not necessary to adjust the dose in the elderly, unless there is also significant renal or hepatic dysfunction (see above and \n                        Geriatric Use in PRECAUTIONS\n                     ).\n                  \n                     Pediatric Patients\n                  \n                  There is no pediatric experience with bisoprolol fumarate tablets.",
    "warningsAndPrecautions_original": "Bisoprolol fumarate tablets, USP, are supplied as 5 mg and 10 mg tablets.\n                  The 5 mg tablet is pink color coated tablet, capsule shaped, convex scored tablets debossed with \u201c6|6\u201d on one side and \u201cS\u201d on the other side, supplied as follows:\n                  bottles of 30  (Unit-of-Use)                      NDC 43547-616-03\n                  bottles of 100                                            NDC 43547-616-10\n                  bottles of 500                                            NDC 43547-616-50\n                  The 10 mg tablet is white color coated tablet, round shaped, convex tablets debossed with \u201c6 7\u201d on one side and \u201cS\u201d on the other side, supplied as follows:\n                  bottles of 30 (Unit-of-Use)                       NDC 43547-617-03\n                  bottles of 100                                            NDC 43547-617-10\n                  bottles of 500                                            NDC 43547-617-50\n                  \n                     Store at 20 oC to 25oC (68 oFto 77oF); excursions permitted to 15 oC to 30oC (59 oFto 86oF) [see USP Controlled Room Temperature].\n                  \n                  \n                     Protect from moisture.\n                  \n                  \n                     Dispense in tight, light resistant containers.\n                  \n                  \n                     Distributed by: \n                  \n                  Solco Healthcare US, LLC\n                  Somerset, NJ 08873, USA\n                  \n                     Manufactured by: \n                  \n                  Prinston Laboratories\n                  Charlotte, NC 28206, USA\n                  \n                     Revised: 06/2023\n                  9040560-01",
    "adverseReactions_original": "Bisoprolol fumarate tablets are contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree AV block, and marked sinus bradycardia.",
    "drug": [
        {
            "name": "Bisoprolol fumarate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3128"
        }
    ]
}